Zenas BioPharma (ZBIO) Retained Earnings (2023 - 2026)
Zenas BioPharma (ZBIO) posted quarterly Retained Earnings of -$846.1 million for Q1 2026, down 219.99% year-over-year from $705.1 million in Q1 2025, and down 1321954.69% quarter-over-quarter from -$64000.0 in Q4 2025.
Zenas BioPharma (ZBIO) Retained Earnings (2023 - 2026) Analysis & Trends
Zenas BioPharma's Retained Earnings history runs 4 years deep, the most recent figure standing at -$846.1 million for Q1 2026.
- In Q1 2026, Retained Earnings fell 219.99% year-over-year to -$846.1 million; the TTM figure through Mar 2026 stood at -$846.1 million (down 219.99% YoY), while the FY2025 annual figure was -$64000.0, down 132.99% from the prior year.
- Retained Earnings for Q1 2026 stood at -$846.1 million, down from -$64000.0 in the prior quarter.
- The five-year high for Retained Earnings was $705.1 million in Q1 2025, with the low at -$846.1 million in Q1 2026.
- The 4-year median for Retained Earnings is -$79000.0 (2025), against an average of -$125.0 million.
- The sharpest annual moves came in 2024 and 2026: Retained Earnings soared 424.32% in 2024, then tumbled 219.99% in 2026.
- Zenas BioPharma's Retained Earnings stood at $37000.0 in 2023, then jumped by 424.32% to $194000.0 in 2024, then tumbled by 132.99% to -$64000.0 in 2025, then plunged by 1321954.69% to -$846.1 million in 2026.
- Business Quant data shows ZBIO's Retained Earnings at -$846.1 million in Q1 2026, -$64000.0 in Q4 2025, and -$524.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Zenas BioPharma | 1.87 Bn | 748.44 Mn | - | 1.21 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.21 Bn |
| Mar 31, 2026 | -846.12 Mn |
| Dec 31, 2025 | -64,000.00 |
| Sep 30, 2025 | -524.70 Mn |
| Jun 30, 2025 | -94,000.00 |
| Mar 31, 2025 | 705.14 Mn |
| Dec 31, 2024 | 194,000.00 |
| Sep 30, 2024 | -334.79 Mn |
| Dec 31, 2023 | 37,000.00 |